Sustainability Requirements for Kellogg’s Suppliers, Supply of Ebola Drug ZMapp Depleted

Kellogg’s is setting targets for suppliers to cut greenhouse gas emissions.

Mapp Biopharmaceutical, the maker of Ebola drug ZMapp, says its supply of the experimental serum has been exhausted.

Target Canada plans supply chain and pricing changes after disappointing losses.

Researchers are working on ethical guidelines for using the vast amounts of data offered up by Internet users.

Share on Procurious

Discuss this:

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.